Utama › Penyakit Huntington › Texas
Kajian klinikal Penyakit Huntington di Texas
6 kajian untuk Penyakit Huntington sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
Pridopidine Phase 3 Study in Huntington's Disease
- UT Health, Houston, McGovern Medical School, Houston
Mengambil pesertaFasa 3
Umur 23 hingga 65 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07609108A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- TX Movement Disorder Spec PLLC, Georgetown
- U of TX Health Science Ct, Houston
Mengambil pesertaFasa 3
Umur 21 hingga 70 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07326709HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
- University of Texas Health Science Center, Houston
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 11 hingga 75 · Semua jantina · Dikemas kini 27 Apr 2026 · NCT02855476Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease
- University of Texas Health Science Center at San Antonio, San Antonio
Mengambil peserta
Umur 18 hingga 85 · Semua jantina · Dikemas kini 11 Feb 2026 · NCT06843252Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease
- The University of Texas Health Science Center at Houston, Houston
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 11 Feb 2026 · NCT05326451Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
- Baylor College of Medicine, Houston
- University of Texas Health Science Center, Houston
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Feb 2024 · NCT01574053Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.